Text of section effective on April 01, 2025
Sec. 549.0401.  DEFINITION.  In this subchapter, "patient assistance program" means a program a pharmaceutical company offers under which the company provides a drug to individuals in need of assistance at no charge or at a substantially reduced cost.  The term does not include the provision of a drug as part of a clinical trial.
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.